Belmont Medical Technologies (Belmont), a leading provider of fluid resuscitation and patient temperature management solutions, today announced the appointment of Brian Larkin as Chief Executive Officer (CEO), effective immediately. Larkin succeeds Brian Ellacott, who has led the company since Audax Private Equity acquired Belmont in 2017 and has recently announced his retirement. Ellacott will remain on the Board as Executive Chair.

Larkin joins Belmont with over three decades of leadership across the medical technology and patient care sectors. Throughout his career Larkin has been characterized by his ability to drive excellence across complex enterprises, oversee strategies that facilitate organic growth, and execute strategic acquisitions to expand market share and help improve financial performance.

Larkin served as President and CEO of Comar, a private equity-owned medical packaging and device manufacturer until its successful exit to Precision Concepts International in October 2025. During his roughly three-and-a-half-year tenure, Larkin led 1,100 employees across 11 factories in a reorganization that generated significant efficiencies while supporting top-line growth. He also previously served as President and CEO of private equity-owned SP Industries for more than four years, where he oversaw revenue and earnings growth prior to its successful sale to ATS Corporation. Larkin also served in executive leadership roles at LifeCell and Integra LifeSciences.

"Belmont has a proud mission of saving lives with The Belmont® Rapid Infuser RI-2 and temperature management products," noted Larkin. "I am honored to join a company with such innovative products and customer trust. I look forward to working with the Belmont team to maintain the company's positive momentum and lead the next stage of growth."

"I am thrilled that Brian Larkin will be joining Belmont as our next Chief Executive Officer," said Brian Ellacott. "Brian is a thoughtful, performance-driven leader with extensive experience in medical devices and patient-care products. He also represents a compelling fit for our innovative culture and mission to deliver breakthrough medical solutions that blend technical inspiration with an uncompromising standard of quality."